Literature DB >> 12945716

Increased expression of insulin-like growth factors in progressive glomerulonephritis of the MRL/lpr mouse.

J A Mohammed1, A Y P Mok, A Parbtani, D G Matsell.   

Abstract

Glomerulonephritis is an important complication of systemic lupus erythematosus (SLE). The tissue distribution and exact role of the insulin-like growth factors (IGFs) in the development of lupus nephritis in the MRL/lpr mouse model have not been established. The present study was undertaken to evaluate the changes over time in mRNA and peptide expression of IGF-I and IGFBP-2 in the MRL/lpr mouse. Using in situ hybridization and immunocytochemistry techniques, the expression of IGF-I and IGFBP-2 in MRL/lpr mouse was examined and compared to their congenic normal MRL-++ mouse counterparts from nine to 24 weeks of age. In the MRL-++ and MRL/lpr mouse kidneys, IGF-I and IGFBP-2 mRNA expression was limited to the cortical and medullary collecting ducts, while their immunoreactivity (IR) was localized to the cortical and medullary collecting ducts, loop of Henle, glomeruli and proximal tubules. Over time, and with progression of disease, the MRL/lpr mice displayed a significant increase in IGF-I IR and a modest increase in IGFBP-2 IR within the outer cortical glomeruli, which was associated with a significant increase in glomerulosclerosis and glomerular cell proliferation and with a significant decrease in renal function. In conclusion, this overexpression of IGF-I and IGFBP-2 within the glomeruli of the MRL/lpr mouse kidney supports their potential role in the alterations in renal function and morphology that accompany lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12945716     DOI: 10.1191/0961203303lu422oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

1.  Is Estrogen a Missing Culprit in Thyroid Eye Disease? Sex Steroid Hormone Homeostasis Is Key to Other Fibrogenic Autoimmune Diseases - Why Not This One?

Authors:  Amy M FitzPatrick
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

2.  Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.

Authors:  Chi Chiu Mok; Hui Hua Ding; Marwa Kharboutli; Chandra Mohan
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-07-28       Impact factor: 4.794

3.  Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic Escherichia coli induced hemolytic uremic syndrome.

Authors:  Yuko Tasaki; Natsumi Inoue; Masaki Shimizu; Naotoshi Sugimoto; Sayaka Ishikawa; Mao Mizuta; Tadafumi Yokoyama; Mondo Kuroda; Kazuhide Ohta; Akihiro Yachie; Taizo Wada
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

Review 4.  Insulin-Like Growth Factor Binding Proteins in Kidney Disease.

Authors:  Shuqiang Wang; Kun Chi; Di Wu; Quan Hong
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

5.  Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses.

Authors:  Xingwang Zhao; Lan Ge; Juan Wang; Zhiqiang Song; Bing Ni; Xiaochong He; Zhihua Ruan; Yi You
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

Review 6.  Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews.

Authors:  Juliana de Andrade Rebouças Guimarães; Silvania da Conceição Furtado; Ana Cyra Dos Santos Lucas; Bruno Mori; José Fernando Marques Barcellos
Journal:  PLoS One       Date:  2022-10-10       Impact factor: 3.752

Review 7.  Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis.

Authors:  Feng Liu; Shougang Zhuang
Journal:  Int J Mol Sci       Date:  2016-06-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.